• Research and Demonstration Projects: There are several ongoing demonstration projects in Australia—VicPrEP in MSM, transgender women, heterosexual serodiscordant couples and people who received N-PEP on more than two occasions; PRELUDE in men and women at high and ongoing risk of HIV; and EPIC-NSW enrolling high-risk, mostly gay and bisexual men in New South Wales. A fourth demonstration project, PrEPX, will start later this year. In November 2016, the South Australian government announced that it would begin a PrEP project to help enable PrEP access in the state. A proposal for a project in Western Australia is under consideration with a decision expected soon.
  • Drug Registration: The Therapeutic Goods Administration has approved daily oral Truvada for HIV prevention.
  • Policy/Regulatory: Australia published Clinical Guidelines in 2017, recommending PrEP be offered if, “the risk of acquiring HIV infection is rated as high according to the eligibility criteria”. Following Therapeutic Goods Administration review, the Pharmaceutical Benefits Scheme also needs to consider Truvada for PrEP for cost subsidization.
  • Advocacy: PrEP’D for Change and #ComePrEPd are working to increase awareness of PrEP in Australia. If you’re an Australian advocate working on PrEP, building a campaign or seeking to share insights and experience, please send info here and PrEPWatch will post it.

Last updated on September 1, 2017.

News Spotlight